|
CN109593133A
|
|
A kind of charge isomer separation method of anti human nerve growth factor antibodies
|
|
CN109206489A
|
|
Protein sequence 12G12 and application thereof
|
|
CN109206488A
|
|
A kind of purification process recombinating AXL inhibitor
|
|
CN109206490A
|
|
Protein sequence 11B09 and application thereof
|
|
CN108918694A
|
|
Derivatization detection method before a kind of remaining HPLC column of MSX
|
|
CN108126186A
|
|
A kind of hydrogel containing nerve growth factor and preparation method thereof
|
|
CN108085337A
|
|
A kind of screening technique of GS expression systems cell line
|
|
CN108059676A
|
|
A kind of anti human nerve growth factor scFv antibody and preparation method
|
|
CN106478801A
|
|
A kind of method separating recombinant human nerve growth factor from mammalian cell cultures
|
|
CN106226428A
|
|
A kind of method of recombinant human nerve growth factor content in quick detection Chinese hamster ovary celI fermentation liquid
|
|
CN105106937A
|
|
Application of nerve growth factor in preparation of drug used for promoting healing of fresh skin wound
|
|
CN102964442A
|
|
Method for preparing polyethylene glycol (PEG) and nerve growth factor (NGF) conjugate
|
|
CN102978211A
|
|
Interest protein preparation method and purpose thereof
|
|
EP2184295A1
|
|
Polypeptides having anticancer activity
|
